Sugammadex

Chemical formula: C₇₂H₁₀₄Na₈O₄₈S₈  Molecular mass: 2,002.12 g/mol  PubChem compound: 6918585

Therapeutic indications

Sugammadex is indicated for:

Routine reversal of rocuronium induced blockade

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Reversal of neuromuscular blockade induced by rocuronium or vecuronium

Population group: only adults (18 years old or older)

Reversal of neuromuscular blockade

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Sugammadex is contraindicated in the following cases:

Severe renal impairment

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2022: BRIDION Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈